Compare CVS Health Corp (CVS) vs JPMorgan Equity Premium Income ETF (JEPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs JPMorgan Equity Premium Income ETF — how do they compare? CVS Health Corp trades at $86.82 (market cap $112.49B), while JPMorgan Equity Premium Income ETF trades at $56.7 (market cap $45.55B). The key difference: CVS Health Corp is far larger — about 2.5× JPMorgan Equity Premium Income ETF's market cap, and CVS Health Corp pays a 3.02% dividend while JPMorgan Equity Premium Income ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and JPMorgan Equity Premium Income ETF for 56 Days on average.
| CVS | JEPI | |
|---|---|---|
Market Cap | $112.49B | $45.55B |
Volume | 8,467,392 | 3,820,809 |
Sector | Health | Income / Options Overlay |
52-Week High | $110.60 | $59.88 |
52-Week Low | $70.08 | $55.29 |
Typical Hold Time | 83 Days | 56 Days |
Enterprise Value | $174.83B | — |
Dividend Yield | 3.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
JEPI trades at $56.45, down 0.16% with a bearish technical outlook. The ETF shows neutral momentum oscillators but bearish moving averages, with key support at $56 and resistance at $57. Recent dividend payments of $0.34-$0.37 highlight its income-focused strategy, though financial ratios remain undisclosed in current data.
JEPI's covered-call strategy provides monthly income but faces headwinds from Fed rate hikes and tax implications. Media sentiment is mixed, emphasizing income benefits versus growth trade-offs. Analyst coverage suggests cautious optimism given institutional inflows, though market volatility and income strategy limitations pose risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About JPMorgan Equity Premium Income ETF
JEPI is an actively managed ETF that seeks to deliver monthly income and stock market exposure with lower volatility. It combines an equity portfolio with an options strategy to generate steady premiums.
Read more on JEPI →
